The US Food and Drug Administration has issued an accelerated approval for the experimental drug Aduhelm for use in patients with early onset Alzheimer's disease.  EPA /DAVID A. WHITE

What does the first Alzheimer’s drug to be approved in 20 years mean for those who have been diagnosed?